These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 31373226)

  • 21. Preparation, characterization and antimicrobial activity of inclusion complex of biochanin A with (2-hydroxypropyl)-β-cyclodextrin.
    Nikolic IL; Savic IM; Popsavin MM; Rakic SJ; Mihajilov-Krstev TM; Ristic IS; Eric SP; Savić-Gajic IM
    J Pharm Pharmacol; 2018 Nov; 70(11):1485-1493. PubMed ID: 30168133
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ERG2 and ERG24 Are Required for Normal Vacuolar Physiology as Well as Candida albicans Pathogenicity in a Murine Model of Disseminated but Not Vaginal Candidiasis.
    Luna-Tapia A; Peters BM; Eberle KE; Kerns ME; Foster TP; Marrero L; Noverr MC; Fidel PL; Palmer GE
    Eukaryot Cell; 2015 Oct; 14(10):1006-16. PubMed ID: 26231054
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antifungal Activity of Ellagic Acid In Vitro and In Vivo.
    Li ZJ; Guo X; Dawuti G; Aibai S
    Phytother Res; 2015 Jul; 29(7):1019-25. PubMed ID: 25919446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determination of the effects of cinnamon bark fractions on Candida albicans and oral epithelial cells.
    Veilleux MP; Grenier D
    BMC Complement Altern Med; 2019 Nov; 19(1):303. PubMed ID: 31703673
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antifungal activity of amphotericin B and voriconazole against the biofilms and biofilm-dispersed cells of Candida albicans employing a newly developed in vitro pharmacokinetic model.
    El-Azizi M; Farag N; Khardori N
    Ann Clin Microbiol Antimicrob; 2015 Apr; 14():21. PubMed ID: 25885806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sentinel surveillance of invasive candidiasis in Spain: epidemiology and antifungal susceptibility.
    Nieto MC; Tellería O; Cisterna R
    Diagn Microbiol Infect Dis; 2015 Jan; 81(1):34-40. PubMed ID: 25439581
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetic Properties of Micafungin in Critically Ill Patients Diagnosed with Invasive Candidiasis.
    Boonstra JM; van der Elst KC; Veringa A; Jongedijk EM; Brüggemann RJ; Koster RA; Kampinga GA; Kosterink JG; van der Werf TS; Zijlstra JG; Touw DJ; Alffenaar JWC
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971861
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis, characterization and antifungal activity of a novel formulated nanocomposite containing Indolicidin and Graphene oxide against disseminated candidiasis.
    Farzanegan A; Roudbary M; Falahati M; Khoobi M; Gholibegloo E; Farahyar S; Karimi P; Khanmohammadi M
    J Mycol Med; 2018 Dec; 28(4):628-636. PubMed ID: 30126717
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Linking the concentrations of itraconazole and 2-hydroxypropyl-β-cyclodextrin in human intestinal fluids after oral intake of Sporanox
    Berben P; Stappaerts J; Vink MJA; Domínguez-Vega E; Somsen GW; Brouwers J; Augustijns P
    Eur J Pharm Biopharm; 2018 Nov; 132():231-236. PubMed ID: 29959034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigation of transport of genistein, daidzein and their inclusion complexes prepared with different cyclodextrins on Caco-2 cell line.
    Daruházi AE; Kiss T; Vecsernyés M; Szente L; Szőke E; Lemberkovics E
    J Pharm Biomed Anal; 2013 Oct; 84():112-6. PubMed ID: 23810850
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Formation of natamycin:cyclodextrin inclusion complexes and their characterization.
    Koontz JL; Marcy JE
    J Agric Food Chem; 2003 Nov; 51(24):7106-10. PubMed ID: 14611179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The continuous changes in the aetiology and epidemiology of invasive candidiasis: from familiar Candida albicans to multiresistant Candida auris.
    Quindós G; Marcos-Arias C; San-Millán R; Mateo E; Eraso E
    Int Microbiol; 2018 Sep; 21(3):107-119. PubMed ID: 30810955
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antifungal activity of the amyrin derivatives and in vitro inhibition of Candida albicans adhesion to human epithelial cells.
    Johann S; Soldi C; Lyon JP; Pizzolatti MG; Resende MA
    Lett Appl Microbiol; 2007 Aug; 45(2):148-53. PubMed ID: 17651210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trends in antifungal susceptibility of Candida species--one year observation.
    Gołaś M; Netsvyetayeva I; Sikora M; Piskorska K; Sulik-Tyszka B; Swoboda-Kopeć E
    Pol J Microbiol; 2014; 63(2):217-22. PubMed ID: 25115116
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antifungal susceptibility profiles of Candida species to triazole: application of new CLSI species-specific clinical breakpoints and epidemiological cutoff values for characterization of antifungal resistance].
    Karabıçak N; Alem N
    Mikrobiyol Bul; 2016 Jan; 50(1):122-32. PubMed ID: 27058336
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antimycotic influence of beta-cyclodextrin complexes--in vitro measurements using laser nephelometry in microtiter plates.
    Fouda MM; Knittel D; Hipler UC; Elsner P; Schollmeyer E
    Int J Pharm; 2006 Mar; 311(1-2):113-21. PubMed ID: 16442247
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The current treatment landscape: candidiasis.
    Bassetti M; Peghin M; Timsit JF
    J Antimicrob Chemother; 2016 Nov; 71(suppl 2):ii13-ii22. PubMed ID: 27880665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacoeconomic analysis of antifungal therapy for primary treatment of invasive candidiasis caused by Candida albicans and non-albicans Candida species.
    Ou HT; Lee TY; Chen YC; Charbonneau C
    BMC Infect Dis; 2017 Jul; 17(1):481. PubMed ID: 28693479
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo and in vitro activity of a bis-arylidenecyclo-alkanone against fluconazole-susceptible and -resistant isolates of Candida albicans.
    de Sá NP; de Paula LFJ; Lopes LFF; Cruz LIB; Matos TTS; Lino CI; de Oliveira RB; de Souza-Fagundes EM; Fuchs BB; Mylonakis E; Johann S
    J Glob Antimicrob Resist; 2018 Sep; 14():287-293. PubMed ID: 29715565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Supramolecular Chitosan Micro-Platelets Synergistically Enhance Anti-Candida albicans Activity of Amphotericin B Using an Immunocompetent Murine Model.
    Grisin T; Bories C; Bombardi M; Loiseau PM; Rouffiac V; Solgadi A; Mallet JM; Ponchel G; Bouchemal K
    Pharm Res; 2017 May; 34(5):1067-1082. PubMed ID: 28168390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.